Dr. Reddy’s Laboratories has scheduled a board meeting on October 24, 2025, to review and approve the unaudited standalone and consolidated financial results for the quarter ending September 30, 2025 (Q2 2025). The trading window for dealing in the company’s securities will be closed from September 24, 2025, to October 26, 2025.
Board Meeting for Q2 2025 Results
Dr. Reddy’s Laboratories is set to convene a meeting of its Board of Directors to consider and approve the financial results for the second quarter of the fiscal year 2025, which ended on September 30, 2025. This crucial meeting is scheduled for October 24, 2025.
Trading Window Closure
In compliance with insider trading regulations, Dr. Reddy’s Laboratories has announced the closure of its trading window. The restriction on trading the company’s securities will be in effect from September 24, 2025, and will continue until October 26, 2025. This measure ensures fair and transparent trading practices during the sensitive period leading up to the earnings announcement.
Source: BSE
